A Study to Evaluate the Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease
Clinical trial NCT05176951 · COMPLETED
Trial details
- NCT number
- NCT05176951
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-22
- Primary completion
- 2024-03-14
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.